Genesee Capital Advisors’s Calix CALX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-52,468
Closed -$4.2M 114
2021
Q4
$4.2M Sell
52,468
-4,046
-7% -$264K 2% 11
2021
Q3
$2.79M Buy
+56,514
New +$2.61M 1.38% 21
2021
Q2
Sell
-62,679
Closed -$2.17M 59
2021
Q1
$2.17M Sell
62,679
-51,650
-45% -$1.91M 1.29% 26
2020
Q4
$3.4M Sell
114,329
-1,123
-1% -$27.7K 2.23% 13
2020
Q3
$2.05M Buy
+115,452
New +$2.18M 1.69% 15

Other funds holding CALX

Genesee Capital Advisors's CALX Position: Q1 2022 in Review

Genesee Capital Advisors sold out of Calix (CALX) in Q1 2022, closing a stake of 52,468 shares — an estimated $4.2M sold.

Genesee Capital Advisors first reported a position in CALX in Q3 2020 and held it in 5 quarters. The position peaked at $4.2M in Q4 2021. 230 funds tracked by Wall St. Rank hold CALX as of Q1 2022.

  • Genesee Capital Advisors reported no remaining Calix position as of Q1 2022 after selling out during the quarter.
  • Genesee Capital Advisors sold 52,468 Calix shares in Q1 2022, an estimated $4.2M.
  • Genesee Capital Advisors first reported a position in Calix in Q3 2020 and held it in 5 quarters.
  • Genesee Capital Advisors's Calix position peaked at $4.2M in Q4 2021.
  • 230 funds tracked by Wall St. Rank held Calix as of Q1 2022.

Based on Genesee Capital Advisors's 13F filing for Q1 2022, filed 25 May 2022.